The following content is involved in the announcements of relevant matters in the Opinions of the General Office of the State Council on Carrying out Quality and Efficacy Consistency Evaluation of Generic Drugs: pharmaceutical products produced in China with the same production line and approved for marketing in the EU, Japan, or the U.S. can be deemed as passing the consistency evaluation after the review and approval by the Consistency Evaluation Office.
